Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Revenue (2016 - 2025)

Historic Revenue for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $209.4 million.

  • Collegium Pharmaceutical's Revenue rose 3142.48% to $209.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $757.1 million, marking a year-over-year increase of 2633.68%. This contributed to the annual value of $631.4 million for FY2024, which is 1141.24% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Revenue stood at $209.4 million for Q3 2025, which was up 3142.48% from $188.0 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Revenue registered a high of $209.4 million during Q3 2025, and its lowest value of $27.4 million during Q4 2021.
  • For the 5-year period, Collegium Pharmaceutical's Revenue averaged around $132.3 million, with its median value being $136.7 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 6412.53% in 2021, then skyrocketed by 37372.27% in 2022.
  • Collegium Pharmaceutical's Revenue (Quarter) stood at $27.4 million in 2021, then skyrocketed by 373.72% to $129.6 million in 2022, then increased by 15.53% to $149.7 million in 2023, then increased by 21.51% to $181.9 million in 2024, then grew by 15.07% to $209.4 million in 2025.
  • Its last three reported values are $209.4 million in Q3 2025, $188.0 million for Q2 2025, and $177.8 million during Q1 2025.